Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Johnson & Johnson

Tracked across 71 events · 3058 articles · First seen Jan 09, 2025 · Last active Sep 22, 2026

Sentiment
13
Attention
10
Events
71
Relationships
18
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 70
Business
Impact: Johnson & Johnson is investing over $1 billion to expand its Vision operations in United States — Jacksonville, Florida, enhancing its manufacturing, packaging, and distribution capabilities for ACUVUE contact lenses. This investment is part of a larger $55 billion commitment to U.S. manufacturing, research, and development, aiming to strengthen its supply chain and meet growing demand.
Jun 15, 2026 · 12 articles
4 70
Regulatory
Impact: As the developer and manufacturer of Guselkumab, Johnson & Johnson benefits from the expanded FDA approval, which enhances the drug's market position and potential sales.
May 28, 2026 · 6 articles
7 80
Tech
Impact: Johnson & Johnson developed amivantamab, a revolutionary cancer treatment that has shown unprecedented results in clinical trials, significantly boosting its reputation and potential market share in oncology.
May 30, 2026 · 20 articles
6 75
Tech
Impact: The company developed and tested Apalutamide, a prostate cancer drug, which showed significant positive results in late-stage trials, potentially expanding its market and revenue.
May 31, 2026 · 6 articles
4 20
Business
Impact: Johnson & Johnson is acquiring Firefly Biotech for $1 billion, expanding its oncology pipeline with the Firelink degrader antibody conjugate platform and preclinical candidates for KRAS-driven tumors. This acquisition strengthens its position in targeted cancer therapies.
Jun 08, 2026 · 13 articles
3 30
Regulatory
Impact: Johnson & Johnson is the defendant in the talc litigation; the judge's doubt on causation is favorable for the company, reducing the risk of large verdicts.
Jul 22, 2026 · 6 articles
4 40
Regulatory
Impact: J&J received FDA authorization for its OTTAVA robotic system, marking its entry into the US soft-tissue robotic surgery market. This approval is a key milestone for its medtech business and positions it to compete with Intuitive Surgical and Medtronic.
Jul 22, 2026 · 20 articles
6 20
Business
Impact: Johnson & Johnson is the defendant proposing the $5.5 billion settlement to resolve most talc lawsuits, which could end a decade-long legal battle and reduce uncertainty.
Jul 27, 2026 · 82 articles
1 0
Business
Multiple articles from Zacks Investment Research analyze the recent stock performance of Johnson & Johnson (JNJ), comparing its daily and monthly returns against major indices such as the S&P 500, Dow Jones Industrial Average, and…
Impact: Johnson & Johnson is the central subject, with its stock performance, earnings estimates, and valuation analyzed. The articles note mixed daily returns and a Hold rating, indicating a neutral market sentiment.
Jul 02, 2025 · 6 articles
4 10
Business
Apollo Global Management is reportedly in talks to acquire Johnson & Johnson's orthopedics unit, Johnson & Johnson — DePuy Synthes, in a deal that could value the business at close to $20 billion, according to…
Impact: J&J is weighing a sale of its Johnson & Johnson — DePuy Synthes orthopedics unit to Apollo or a spinoff, part of its effort to focus on higher-growth healthcare segments; the unit generated $9.3 billion in 2025 sales.
Sep 11, 2026 · 6 articles
4 70
Tech
Impact: Johnson & Johnson>>> is an Assistant Professor at the Terasaki Institute for Biomedical Innovation>>> and a key researcher in the development of the 4-AP gel. His involvement highlights his expertise and contributes to his professional reputation.
Jun 04, 2026 · 6 articles
2 40
Business
Impact: Johnson & Johnson is a key player in the antibody therapeutics market, benefiting from the projected market growth.
Jul 28, 2026 · 6 articles
1 60
Business
Impact: Key player; growth forecast positive for its medical devices segment.
Jul 21, 2026 · 8 articles
1 0
Domestic
Impact: Johnson & Johnson is a U.S. Representative challenging Larry Rhoden in the Republican primary for governor. His participation makes the gubernatorial race highly competitive.
Jun 01, 2026 · 6 articles
4 15
Business
Impact: Johnson & Johnson Innovation - JJDC, Inc., Johnson & Johnson's corporate venture capital arm, participated in the Series C financing, indicating its strategic interest in neurological disease treatments and potential future collaborations or acquisitions.
Jun 04, 2026 · 6 articles
8 20
Accidents
Impact: Johnson & Johnson Innovative Medicine is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.
May 15, 2026 · 446 articles
2 10
Business
Impact: Parent company; acquisition demonstrates commitment to orthopedics despite potential sale of Johnson & Johnson — DePuy Synthes.
Jul 16, 2026 · 6 articles
2 10
Tech
A UCL-led clinical trial in Africa, the LATA (Long-Acting Treatment in Adolescents) trial, found that long-acting injectable antiretroviral therapy given every eight weeks was more effective than daily tablets at maintaining viral suppression in adolescents…
Impact: Johnson & Johnson Innovative Medicines funded the trial and provided injectable rilpivirine, potentially benefiting from wider adoption of the regimen.
Sep 17, 2026 · 12 articles
3 50
Tech
Impact: Major contributing member; participates in pre-competitive research space.
Jul 13, 2026 · 6 articles
2 10
Business
The 2026 China International Fair for Trade in Services (CIFTIS) was held from September 9 to 13 at Shougang Park in China — Beijing, themed Global Services, Shared Prosperity. The fair drew participants from 90…
Impact: Participated as an exhibitor, showcasing its healthcare and services offerings.
Sep 09, 2026 · 21 articles
6 60
Tech
Impact: Johnson & Johnson has invested in AI-powered platforms to enhance decision-making and streamline development processes, reflecting the industry's adoption of intelligent manufacturing.
Apr 07, 2026 · 8 articles
3 20
Business
Impact: Johnson & Johnson had a senior talent executive on the panel, indicating its interest in refining HiPo programs and potentially adopting Talogy's recommendations.
Jun 03, 2026 · 6 articles
2 0
Business
Impact: Johnson & Johnson, through its subsidiary Johnson & Johnson — Janssen Pharmaceuticals, Inc., is a licensee of ICOTYDE, a drug jointly discovered with AnBogen Therapeutics.
May 28, 2026 · 6 articles
4 -10
Business
Impact: Johnson & Johnson faces new competition in the treatment-resistant depression market as Lilly's acquisition of Atai Life Sciences positions BPL-003 as a potential rival to J&J's Spravato.
Jul 16, 2026 · 25 articles
4 -5
Regulatory
Impact: Johnson & Johnson is among companies that have reduced emphasis on diversity in board recruitment, reflecting the broader trend.
Jul 28, 2026 · 6 articles
2 10
Business
On September 8, 2026, AnBogen Therapeutics announced that its Board of Directors authorized a share repurchase program of up to $300 million of its outstanding common stock. The company plans to fund the repurchases using…
Impact: Johnson & Johnson is a collaboration partner for ICOTYDE, and its royalty payments contribute to funding the repurchase. The event underscores the commercial value of the partnership.
Sep 08, 2026 · 7 articles
2 5
Tech
A study published on Sept. 17, 2026 in Science identified the inherited EGFR T790M mutation as a major risk factor for lung cancer, especially in never-smokers. Researchers led by Jaclyn LoPiccolo and Pasi A. Jänne…
Impact: Johnson & Johnson's Rybrevant is another EGFR-targeted therapy referenced; the study could support broader use of these treatments.
Sep 17, 2026 · 6 articles
2 0
Tech
Impact: Johnson & Johnson is a researcher at La Trobe University who commented on the study, highlighting the novelty of rapid cell wall changes.
Jun 11, 2026 · 6 articles
10 0
International
Impact: Johnson & Johnson, a supply chain consultant, warns that the war's impact on costs will filter through supply chains for the rest of the year, leading to bigger problems if oil shortages persist.
May 05, 2026 · 374 articles
4 -10
Domestic
Impact: Johnson & Johnson, a Republican Representative, voiced frustration over the current state of Congress, stating that many colleagues have 'forgotten how to govern'.
Jun 29, 2026 · 17 articles
+ 41 more events View on Dashboard
Kenvue ↔ Johnson & Johnson
Kenvue ↔ Johnson & Johnson
Sanofi ↔ Johnson & Johnson
Sanofi ↔ Johnson & Johnson
Japan ↔ Johnson & Johnson
Japan ↔ Johnson & Johnson
Donald Trump ↔ Johnson & Johnson
Donald Trump ↔ Johnson & Johnson
Nigeria ↔ Johnson & Johnson
Nigeria ↔ Johnson & Johnson
United States ↔ Johnson & Johnson
United States ↔ Johnson & Johnson
India ↔ Johnson & Johnson
India ↔ Johnson & Johnson
ERGEN INTELLIGENCE
Track Johnson & Johnson live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.